Home
>
National Drug Code (NDC)
>
TERCONAZOLE
TERCONAZOLE - 0591-3196-89 - (TERCONAZOLE)
Drug Information of TERCONAZOLE
| Product NDC: | 0591-3196 |
| Proprietary Name: | TERCONAZOLE |
| Non Proprietary Name: | TERCONAZOLE |
| Active Ingredient(s): | 4 mg/g & nbsp; TERCONAZOLE |
| Administration Route(s): | VAGINAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TERCONAZOLE
| Product NDC: | 0591-3196 |
| Labeler Name: | Watson Laboratories, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019579 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20040401 |
Package Information of TERCONAZOLE
| Package NDC: | 0591-3196-89 |
| Package Description: | 1 TUBE, WITH APPLICATOR in 1 CARTON (0591-3196-89) > 45 g in 1 TUBE, WITH APPLICATOR |
NDC Information of TERCONAZOLE
| NDC Code | 0591-3196-89 |
| Proprietary Name | TERCONAZOLE |
| Package Description | 1 TUBE, WITH APPLICATOR in 1 CARTON (0591-3196-89) > 45 g in 1 TUBE, WITH APPLICATOR |
| Product NDC | 0591-3196 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TERCONAZOLE |
| Dosage Form Name | CREAM |
| Route Name | VAGINAL |
| Start Marketing Date | 20040401 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Watson Laboratories, Inc |
| Substance Name | TERCONAZOLE |
| Strength Number | 4 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |
